Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.
about
Cognitive neuropsychology of HIV-associated neurocognitive disordersHuman CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementiaAntioxidant protection from HIV-1 gp120-induced neuroglial toxicityHIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderHIV Associated Neurocognitive DisordersRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersCognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersSynaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsHIV and antiretroviral therapy in the brain: neuronal injury and repairDisruption of neuronal autophagy by infected microglia results in neurodegenerationMethamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: relevance for HIV associated neurocognitive disordersMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesM- and T-tropic HIVs promote apoptosis in rat neuronsEffects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismNeonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology.The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis.Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes.Persistent hijacking of brain proteasomes in HIV-associated dementia.CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapyEvidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective casesGene expression patterns associated with neurological disease in human HIV infectionMethamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersNeurobehavioral effects of HIV-1 infection in China and the United States: a pilot studyRetrograde and anterograde transport of HIV protein gp120 in the nervous system.Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation.Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementiaNeuropsychiatric manifestations of HIV infection and AIDSNeurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportIbudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells
P2860
Q22252615-3DA89AB7-85D3-4BDA-BD7C-613E23F7E0A8Q24794489-49B334A7-BE4B-449B-B4EC-68909D1FDAECQ24794513-5401AC49-12E0-4908-B51B-3BF30147B3FBQ26859071-1FC9D924-644A-49E8-AD76-B235415E37BBQ26865707-D9765F05-6734-4E66-862F-CF35C410DED8Q27023968-F21E855B-50E2-44D9-B88E-F4BE097312F1Q27025573-CA17033D-F9B0-48E1-B366-831694613C8EQ27311532-27C94D52-884A-49F9-92B2-3C04AEEE1295Q28082139-1212ED84-989A-4D55-9A54-52B9A654FD02Q28088477-FEAE37F9-F0A7-4CB1-9CC1-68B307C76969Q28279808-36FF1959-88FD-4E41-8AD4-8DB0330B7016Q28473257-2CC43757-9BC1-4E27-9BF1-8068CE7E5849Q28483960-8CCCEC57-B940-409F-9C30-05A962D381E4Q28539889-0287AB45-8508-4E92-9DB4-44DC9BD9E635Q28572213-F6E48E72-3161-41E0-BABA-C68EB9EADE3EQ28660034-96C42281-AB7F-41A6-861E-A60DF31E6EDCQ30399828-F7A16096-FD33-4777-8F05-459299F8F122Q30497248-CDA3553E-B77F-4CB8-9725-6DD2A8C1FD97Q30569766-49180502-6078-4D02-B1D9-D7D179DEFB73Q30712330-061438DF-A6BF-43E3-962F-6A16AEF87F23Q31104394-11A2E3CC-9D91-44C3-B3A9-29506F58406AQ32066108-1B0A5C65-3F52-40A9-AC2D-8A92F4968EB8Q33495226-8F44E83E-6E8C-494B-BF10-1DCCC68FA56DQ33520783-848853CF-D7D1-42AD-87B3-54064CF0D8E4Q33552227-909CA4E6-08D2-45EA-B77B-7D312CB82E6DQ33570376-FF68F882-D289-47D4-AE03-1915E7E15812Q33605737-A38333F6-034B-48C1-AF94-7EB825297FD0Q33624189-C1305701-FF3D-47AF-9318-29F66067FBB6Q33631688-5366AF1A-D366-4503-858A-6A4AAA8BD0F4Q33649838-62C74C50-247F-4BD9-AAF2-C3D3CA8B1790Q33700996-22C9695E-4261-4A6B-8CD7-B46FC25C06DBQ33716348-33AF9332-D49A-4228-9CEC-815F15D27FFBQ33734695-C9D70A5B-C5EF-4AD6-B648-C178694BF0C6Q33801157-F71C1921-FD34-44F9-BC6D-DE27BC7B04D8Q33802715-A734F9E8-63AB-4087-B7DE-206FB18F35F5Q33803617-5BC50A65-0F5B-48BC-882C-A8E77C421C5DQ33843573-5E499D2D-D46A-4D6E-9653-CECBF60590FCQ33868874-8CA273A3-7238-4051-ABDD-89749D6DEF33Q33870898-45ECD13A-4F17-44C3-833B-B44940D018BBQ33873538-7E5EAD3E-0A62-46AD-980E-A53F2C4592A2
P2860
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Dendritic injury is a patholog ...... urobehavioral Research Center.
@en
Dendritic injury is a patholog ...... urobehavioral Research Center.
@nl
type
label
Dendritic injury is a patholog ...... urobehavioral Research Center.
@en
Dendritic injury is a patholog ...... urobehavioral Research Center.
@nl
prefLabel
Dendritic injury is a patholog ...... urobehavioral Research Center.
@en
Dendritic injury is a patholog ...... urobehavioral Research Center.
@nl
P2093
P356
P1433
P1476
Dendritic injury is a patholog ...... urobehavioral Research Center.
@en
P2093
Atkinson JH
Marcotte TD
McCutchan JA
P304
P356
10.1002/ANA.410420618
P577
1997-12-01T00:00:00Z